ArticleCancer cell international2023

Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy.

Yang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.